Clinical Trial Update: Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic interaction study evaluating potential interactions between GSK3640254 and several common drugs in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Caffeine (caffeine)
• DIGOXIN (Digoxin)
• Flurbiprofen (flurbiprofen)
• GSK3640254
• METOPROLOL (METOPROLOL TARTRATE)
• Midazolam (Midazolam)
• Montelukast (Montelukast)
• Omeprazole (Omeprazole)
• Pravastatin (pravastatin)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2022-05-23